Pravastatin improves low-density lipoprotein oxidation in renal transplantation.
Cofan
F
F
Renal Transplant Unit, Lipid Section, Biochemistry Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Zambon
D
D
Laguna
J C
JC
Casals
E
E
Ros
E
E
Cofan
M
M
Campistol
J M
JM
Oppenheimer
F
F
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000517:prevention & control; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000453:epidemiology*; D016030:Kidney Transplantation / Q000502:physiology*; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood* / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D018579:Patient Selection; D011183:Postoperative Complications / Q000517:prevention & control; D017035:Pravastatin / Q000627:therapeutic use*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D017035:Pravastatin